Press Releases Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 04:00:02 2024-05-08 pm EDT			5-day change	1st Jan Change
775 ^USD	-0.36%		-0.23%	+32.95%

May. 08	China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target	MT
May. 07	Coca Cola's new bond prices tight, investors still hungry for new debt	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eli Lilly and : Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease	May. 07	PU
Lilly Declares Second-Quarter 2024 Dividend	May. 06	PR
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	Apr. 30	AQ
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues	Apr. 30	AQ
Eli Lilly and : Q1 Earnings 2024 Press Release	Apr. 30	PU
Eli Lilly and : Q1 Earnings 2024 Earnings Presentation	Apr. 30	PU
Lilly: Q1 Earnings Snapshot	Apr. 30	AQ
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum	Apr. 30	PR
Eli Lilly and : Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC	Apr. 26	PU
ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting	Apr. 23	AQ
Eli Lilly and : Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals	Apr. 22	PU
6 Stocks Positioned to Soar as Investors Focus on MASH	Apr. 22	AQ
United Airlines, Eli Lilly rise; JB Hunt, Travelers fall, Wednesday, 4/17/2024	Apr. 17	AQ
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement	Apr. 16	PR
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib in Women with ER+/HER2- Breast Cancer	Apr. 16	AQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	Apr. 10	AQ
Lilly - Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance on risk of heart failure hospitalization and death in adults following a heart attack	Apr. 08	AQ
Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack	Apr. 06	PU
Eli Lilly and : Q1 Earnings 2024 Estimated Acquired IPR&D And Development Milestone Charges	Apr. 05	PU
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug	Mar. 08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT